Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury
Recruiting
Observational Study
Spinal Cord Injuries
Endothelial Dysfunction
Testosterone Deficiency
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 89
- Sex
- Male
- Study type
- Observational
- Participants needed
- 48 (estimated)
- Sponsor
- Craig Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Heart attacks and strokes are among the most common causes of premature death in individuals living with spinal cord injury (SCI) and appear to occur earlier in life. The factors that lead to the heighten and accelerated risk of heart attacks and strokes in adults living with SCI remain poorly understood. The investigators aim to uncover why this happens and find ways to prevent it. Our research f…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Between ages 18-89 years of age
* Male Sex
* History of motor complete (AIS A/B) paraplegia (NLI T3 or Below)
* Time since injury \<6 months at time of enrollment (Subacute injury)
* Testosterone Deficiency defined as \< 300ng/dL
Exclusion Criteria:
* Overt cardiovascular di…
Contacts